XML 71 R60.htm IDEA: XBRL DOCUMENT v3.23.3
Segment Data (Schedule of Net Sales from External Customers by Products) (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended 9 Months Ended
Sep. 29, 2023
Sep. 30, 2022
Sep. 30, 2022
Jun. 16, 2022
Sep. 29, 2023
Segment Reporting Information          
Net sales $ 497.0 $ 550.4 $ 465.4 $ 874.6 $ 1,396.6
Specialty Brands | Operating Segments          
Segment Reporting Information          
Net sales 286.2 361.7 303.5 587.1 818.3
Specialty Generics          
Segment Reporting Information          
Net sales 210.8 188.7 161.9 287.5 578.3
Specialty Generics | Operating Segments          
Segment Reporting Information          
Net sales 210.8 188.7 161.9 287.5 578.3
Acthar | Specialty Brands          
Segment Reporting Information          
Net sales 122.1 153.2 125.7 221.9 320.9
Inomax | Specialty Brands          
Segment Reporting Information          
Net sales 72.9 94.2 80.7 165.8 232.5
Therakos immunotherapy | Specialty Brands          
Segment Reporting Information          
Net sales 66.0 68.2 58.0 109.6 187.6
Amitiza [Member] | Specialty Brands          
Segment Reporting Information          
Net sales [1] 18.3 42.9 37.1 81.5 61.4
Other | Specialty Brands          
Segment Reporting Information          
Net sales 2.5 3.2 2.0 8.3 5.9
Opioids | Specialty Generics          
Segment Reporting Information          
Net sales 65.9 55.2 46.5 88.8 200.2
ADHD | Specialty Generics          
Segment Reporting Information          
Net sales 41.5 13.4 11.6 17.5 82.9
Addiction Treatment | Specialty Generics          
Segment Reporting Information          
Net sales 15.1 19.1 16.6 30.0 46.8
Other Generics | Specialty Generics          
Segment Reporting Information          
Net sales 3.4 3.0 2.9 4.9 7.6
Generics | Specialty Generics          
Segment Reporting Information          
Net sales 125.9 90.7 77.6 141.2 337.5
Controlled substances | Specialty Generics          
Segment Reporting Information          
Net sales 22.0 21.4 19.7 37.6 61.4
APAP | Specialty Generics          
Segment Reporting Information          
Net sales 57.4 69.2 57.9 96.5 163.6
Other API | Specialty Generics          
Segment Reporting Information          
Net sales 5.5 7.4 6.7 12.2 15.8
API | Specialty Generics          
Segment Reporting Information          
Net sales 84.9 98.0 84.3 146.3 240.8
Terlivaz | Specialty Brands          
Segment Reporting Information          
Net sales $ 4.4 $ 0.0 $ 0.0 $ 0.0 $ 10.0
[1] Amitiza consists of both product net sales and royalties. Refer to Note 3 for further details on Amitiza's revenues.